Grant: Doctoral Research Award: Canada Graduate Scholarships
McGill University
$120,000.00
Understanding the Genomic and Cellular Landscape of Advanced Basal Cell Carcinoma (BCC)
FY 2024-25
Summary
Skin cancers are the most common type of cancer, with Basal Cell Carcinoma (BCC) being the most frequent. Over 30% of people develop BCC in their lifetime, with rates rising to 40% in fair-skinned individuals. While most BCCs remain on the skin and can be removed surgically, some become more aggressive, damaging surrounding skin and tissue, and even spreading to other organs. We know little about how advanced BCCs (adBCC) occur, and current treatment options are ineffective. The physical effects, along with the emotional toll of disfigurement and reduced quality of life, highlight the urgent need to learn why certain BCCs become aggressive. Our lab re-analyzed complex genetic information from other studies and discovered new genes and pathways (groups of genes) that may be linked to aggressive behavior and treatment resistance. We also found changes in the immune system and support cells around the tumor that might play a role in this process. Our project focuses on understanding the DNA mutations and gene activity in adBCCs compared to routine BCCs. By examining these tumors at a very detailed, single-cell level, we hope to identify which changes drive their aggressive behavior. We will combine this data with clinical information, such as the patient's gender, tumor location, and appearance under a magnifying instrument dermatologists use called a dermatoscope. By understanding what makes adBCCs aggressive at the molecular and cellular level, we aim to raise awareness about this common but understudied form of cancer. Long wait times to see dermatologists, especially in rural areas, make early detection difficult. Our goal is to create an easy-to-use tool for doctors, including general practitioners, to help identify aggressive BCCs sooner and speed up treatment. In addition, our research could uncover new drug targets, help create laboratory models for further study, and ultimately prevent complications like tissue destruction or cancer spreading to other organs.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
518891
Name
Ghezelbash Sarah
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Understanding the Genomic and Cellular Landscape of Advanced Basal Cell Carcinoma (BCC)
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Basal Cell Carcinoma; Genomics; Proteomics; Rna Deconvolution; Skin Cancer; Transcriptomics; Tumour Microenvironment
Abstract
Skin cancers are the most common type of cancer, with Basal Cell Carcinoma (BCC) being the most frequent. Over 30% of people develop BCC in their lifetime, with rates rising to 40% in fair-skinned individuals. While most BCCs remain on the skin and can be removed surgically, some become more aggressive, damaging surrounding skin and tissue, and even spreading to other organs. We know little about how advanced BCCs (adBCC) occur, and current treatment options are ineffective. The physical effects, along with the emotional toll of disfigurement and reduced quality of life, highlight the urgent need to learn why certain BCCs become aggressive. Our lab re-analyzed complex genetic information from other studies and discovered new genes and pathways (groups of genes) that may be linked to aggressive behavior and treatment resistance. We also found changes in the immune system and support cells around the tumor that might play a role in this process. Our project focuses on understanding the DNA mutations and gene activity in adBCCs compared to routine BCCs. By examining these tumors at a very detailed, single-cell level, we hope to identify which changes drive their aggressive behavior. We will combine this data with clinical information, such as the patient's gender, tumor location, and appearance under a magnifying instrument dermatologists use called a dermatoscope. By understanding what makes adBCCs aggressive at the molecular and cellular level, we aim to raise awareness about this common but understudied form of cancer. Long wait times to see dermatologists, especially in rural areas, make early detection difficult. Our goal is to create an easy-to-use tool for doctors, including general practitioners, to help identify aggressive BCCs sooner and speed up treatment. In addition, our research could uncover new drug targets, help create laboratory models for further study, and ultimately prevent complications like tissue destruction or cancer spreading to other organs.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ghezelbash, Sarah
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~